Aurobindo Pharma Ltd. · Q3FY26
Result on 9 Feb 2026, first traded on 10 Feb 2026; judged on 15 Sep 2026. The last read before it, on 7 Feb 2026 (2 days ahead), called it favourable, rank 111 of 367 reporting; the share then stayed within 2% of the market over ten sessions. The company's page →
flat / no callverdict
favourablethe read
-1.6%vs market, 10 sessions
-4.7%T+1
1 · What the read said
morning of 7 Feb- Read
- favourable — rank 111 of 367 reporting that week
- Composite
- 59.6 out of 100
- Evidence
- full · 14 results on record
- Expected move
- ±2.8% on the day — its average absolute move on results
- Habit
- continuation — the day-one move usually carries on over the following sessions
- Close that morning
- ₹1,191.00
Reactivity · 30%
27
Momentum · 20%
69
vs market · 30%
65
vs sector · 20%
92
Each layer is a percentile among that week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 26.5 + 0.20 × 69.1 + 0.30 × 64.8 + 0.20 × 92.2 = 59.6
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹1,203.70the base every move below is measured from
T+1-4.7%a real move — at least 60% of its usual
T+10-3.3%market -1.7% · sector +1.5%
vs market-1.6%vs sector -4.8%
Best close after-1.4%traded as high as +1.2% on 10 Feb
Worst close after-6.6%traded as low as -8.1% on 10 Feb
Run-up, 30 sessions-0.2%into the result
52-week range4% below high18% above low
- Delivery share
- -0.8 points in the fortnight before, against the month before that
- Volume
- 2.26× its prior month, in the fortnight before
- Habit held
- continuation — could not be checked
- Announced
- Tue, timing unknown
- Peers reporting
- 8 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Volume ran 2.3x its prior month in the fortnight before.
- 8 sector peers reported the same week; the sector read may already have been set.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
1 mornings| Morning | Days ahead | Read | Rank | Comp. | L1 | L2 | L3 | L4 | Close | Note |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Feb judged simulated | 2 | favourable | 111/367 | 59.6 | 27 | 69 | 65 | 92 | ₹1,191.00 |
A read is made each morning the company is due within seven days. The highlighted morning is the last one before the result — the read this post-mortem judges. Excluded mornings show why the name dropped out that day.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-28 | 29 Dec | 1,206.20 | 1,214.10 | 1,192.30 | 1,200.10 | — | -0.30% | +0.29% | +1.29% |
| T-27 | 30 Dec | 1,202.00 | 1,208.90 | 1,179.00 | 1,186.30 | -1.15% | -1.45% | +0.28% | +1.12% |
| T-26 | 31 Dec | 1,185.00 | 1,193.80 | 1,178.00 | 1,183.00 | -0.28% | -1.72% | +1.01% | +1.94% |
| T-25 | 1 Jan | 1,190.00 | 1,197.00 | 1,170.20 | 1,193.00 | +0.85% | -0.89% | +1.08% | +1.53% |
| T-24 | 2 Jan | 1,200.70 | 1,217.50 | 1,192.00 | 1,215.40 | +1.88% | +0.97% | +1.78% | +2.24% |
| T-23 | 5 Jan | 1,220.00 | 1,222.00 | 1,199.00 | 1,207.40 | -0.66% | +0.31% | +1.48% | +2.03% |
| T-22 | 6 Jan | 1,210.00 | 1,238.80 | 1,207.60 | 1,231.30 | +1.98% | +2.29% | +1.20% | +3.75% |
| T-21 | 7 Jan | 1,236.40 | 1,270.80 | 1,225.20 | 1,235.40 | +0.33% | +2.63% | +1.06% | +4.47% |
| T-20 | 8 Jan | 1,236.00 | 1,236.00 | 1,203.00 | 1,206.10 | -2.37% | +0.20% | +0.04% | +3.01% |
| T-19 | 9 Jan | 1,206.00 | 1,211.40 | 1,188.00 | 1,198.70 | -0.61% | -0.42% | -0.71% | +2.11% |
| T-18 | 12 Jan | 1,193.10 | 1,197.80 | 1,166.50 | 1,172.90 | -2.15% | -2.56% | -0.30% | +1.69% |
| T-17 | 13 Jan | 1,185.00 | 1,185.00 | 1,154.40 | 1,167.70 | -0.44% | -2.99% | -0.52% | +1.22% |
| T-16 | 14 Jan | 1,165.00 | 1,189.10 | 1,158.00 | 1,180.10 | +1.06% | -1.96% | -0.78% | +0.96% |
| T-15 | 16 Jan | 1,174.20 | 1,195.50 | 1,166.30 | 1,172.70 | -0.63% | -2.58% | -0.67% | -0.33% |
| T-14 | 19 Jan | 1,167.00 | 1,177.00 | 1,160.10 | 1,167.60 | -0.43% | -3.00% | -1.09% | -0.69% |
| T-13 | 20 Jan | 1,167.60 | 1,167.70 | 1,137.10 | 1,141.70 | -2.22% | -5.15% | -2.45% | -2.59% |
| T-12 | 21 Jan | 1,133.90 | 1,160.60 | 1,116.50 | 1,121.70 | -1.75% | -6.81% | -2.74% | -3.17% |
| T-11 | 22 Jan | 1,130.10 | 1,149.00 | 1,130.10 | 1,145.30 | +2.10% | -4.85% | -2.23% | -1.63% |
| T-10 | 23 Jan | 1,145.30 | 1,150.50 | 1,120.80 | 1,132.50 | -1.12% | -5.92% | -3.16% | -2.55% |
| T-9 | 27 Jan | 1,139.80 | 1,139.80 | 1,116.20 | 1,129.70 | -0.25% | -6.15% | -2.67% | -2.25% |
| T-8 | 28 Jan | 1,133.00 | 1,143.00 | 1,122.20 | 1,139.90 | +0.90% | -5.30% | -2.03% | -2.47% |
| T-7 | 29 Jan | 1,140.40 | 1,154.10 | 1,127.20 | 1,150.60 | +0.94% | -4.41% | -1.73% | -3.26% |
| T-6 | 30 Jan | 1,190.00 | 1,219.00 | 1,174.00 | 1,207.70 | +4.96% | +0.33% | -2.11% | -2.58% |
| T-5 | 2 Feb | 1,172.10 | 1,185.00 | 1,152.30 | 1,171.00 | -3.04% | -2.72% | -3.01% | -3.32% |
| T-4 | 3 Feb | 1,230.00 | 1,247.30 | 1,211.20 | 1,226.10 | +4.71% | +1.86% | -0.54% | -0.41% |
| T-3 | 4 Feb | 1,226.10 | 1,237.40 | 1,166.00 | 1,212.70 | -1.09% | +0.75% | -0.35% | -0.74% |
| T-2 | 5 Feb | 1,212.70 | 1,212.70 | 1,176.90 | 1,181.60 | -2.56% | -1.84% | -0.87% | -0.77% |
| T-1 | 6 Feb | 1,181.00 | 1,195.90 | 1,166.00 | 1,191.00 | +0.80% | -1.06% | -0.67% | -1.48% |
| base | 9 Feb | 1,191.00 | 1,210.00 | 1,171.50 | 1,203.70 | +1.07% | +0.00% | +0.00% | +0.00% |
| T+1 | 10 Feb result | 1,208.00 | 1,218.70 | 1,106.00 | 1,124.10 | -6.61% | -6.61% | +0.26% | -0.36% |
| T+2 | 11 Feb | 1,136.00 | 1,161.00 | 1,124.20 | 1,146.60 | +2.00% | -4.74% | +0.33% | +0.64% |
| T+3 | 12 Feb | 1,146.60 | 1,163.00 | 1,132.10 | 1,157.90 | +0.99% | -3.80% | -0.23% | +0.43% |
| T+4 | 13 Feb | 1,149.10 | 1,157.40 | 1,126.80 | 1,145.60 | -1.06% | -4.83% | -1.53% | -0.43% |
| T+5 | 16 Feb | 1,142.00 | 1,187.20 | 1,141.90 | 1,184.60 | +3.40% | -1.59% | -0.71% | +0.50% |
| T+6 | 17 Feb | 1,184.60 | 1,212.80 | 1,167.70 | 1,186.70 | +0.18% | -1.41% | -0.55% | +0.92% |
| T+7 | 18 Feb | 1,188.60 | 1,193.50 | 1,129.20 | 1,159.60 | -2.28% | -3.66% | -0.19% | +1.13% |
| T+8 | 19 Feb | 1,156.40 | 1,200.90 | 1,156.40 | 1,171.40 | +1.02% | -2.68% | -1.60% | +0.62% |
| T+9 | 20 Feb | 1,173.80 | 1,178.20 | 1,149.10 | 1,158.80 | -1.08% | -3.73% | -1.14% | +0.73% |
| T+10 | 23 Feb | 1,166.10 | 1,174.20 | 1,143.30 | 1,150.60 | -0.71% | -4.41% | -0.60% | +1.29% |
| T+11 | 24 Feb | 1,156.30 | 1,167.20 | 1,144.00 | 1,164.40 | +1.20% | -3.26% | -1.71% | +1.53% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.